GnRH agonist vs. hCG for triggering of ovulation--differential effects on gene expression in human granulosa cells.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 24603682.
- Also identified by DOI 10.1371/journal.pone.0090359 and PMC identifier 3946044.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate the mRNA expression of genes related to steroidogenesis and OHSS in granulosa cells (GCs) of patients triggered with GnRH agonist compared to patients triggered with hCG. Mural GCs were obtained at the time of oocyte retrieval and gene expression was analyzed using quantitative real time RT-PCR. Single center, case control study. 24 women who were treated with GnRH agonist or hCG for triggering of ovulation. GC collection. The expression of genes related to steroidogenesis and OHSS in mural GCs. The fertilization rate was similar in the two groups. The mRNA expression of CYP19A1 (0.50 vs 1, arbitrary unit), CYP11A1 (0.6 vs. 1) and 3 beta hydroxysteroid-dehydrogenase (0.39 vs 1) was significantly lower in the GnRH group. The expression of VEGF (0.74 vs. 1) and inhibin β B (0.38 vs 1) was lower in the GnRH analog triggered group. Expression of genes related to steroidogenesis is lower at the time of oocyte retrieval in patients triggered with GnRH agonist. The decreased expression of VEGF and inhibin β B in the GnRH agonist group can explain the mechanism of early OHSS prevention.
Medical subject headings
- Gonadotropin-Releasing Hormone
- Granulosa Cells
- Ovulation
- Triptorelin Pamoate